Video Summary - The Exact Formula to Pick Stocks in 25 Mins by ₹4,000 Crore Wealth Manager Formula

Finance-focused summary (stock-picking framework + filters)

Core idea

The discussion centers on identifying “underdog / multibagger” stocks using a structured screening process focused on:

Profitability & margin expansion
Innovation
Learning mindset & ethics
Valuation & cash-flow quality

It also emphasizes investor suitability (psychology, time, knowledge) plus risk controls (position sizing, liquidity checks, diversification vs concentration).

“5 questions” before filtering stocks (investor readiness)

Before stock selection, the presenter asks retail investors:

Emotional tolerance to drawdowns If the market falls 30–50% tomorrow, can you accept potentially large declines? Examples cited:
- Nvidia fell ~50% multiple times over ~5 years
- Apple fell ~50% multiple times over ~10–15 years
Time horizon & life dependence Ensure you’re not investing on a “life and death” basis; long-term commitment matters.
Knowledge / area of strength Invest in industries you understand (the presenter cites his own banking strength; others may have FMCG/consumption knowledge).
Time available for research It’s not “buy-and-forget.” You must be able to track companies, attend earnings calls, and monitor numbers—described as a full-time job.
Goal/fortune-building focus (future corpus) The goal is to build wealth over time—“take it now so you can benefit.”

Methodology: “MILES” framework (step-by-step logic)

The framework is presented as “MILES,” with the following components:

M = Margins / margin expansion with sales growth

Growth alone is not enough—margins must expand.
Example: Maruti
- Sales increased (car prices/sales value mentioned),
- but margins fell from double digit to single digit,
- resulting in weak stock returns for ~6–7 years when margins trended down.

Interpretation / caution

Consistently decreasing margins can indicate:
- customers aren’t paying a premium, and/or
- the business is becoming more commoditized.
One-off margin dips may be temporary, but sustained decline is a red flag.

I = Innovation (value addition / RAD)

Margin is treated as a reflection of innovation and value-add.

Pharma / CDMO example: Neuland Labs
- shift from simpler APIs to more complex peptides and CDMO (contract manufacturing).

The presenter also references “RAD” (continuous R&D / advancing drug development and commercialization) as a wealth driver in successful pharma innovation cycles.

Examples mentioned:

Sun Pharma: described as doing “less innovation”
Laurus Labs: continued expansion/RAD; claim of:
- ~25% staff scientists
- ~1200 scientists out of ~5000 employees

Drug references include:

Mounjaro (GLP-1)
Alli (context unclear due to subtitle errors)

L = Learning mindset / management hunger

Look for promoters/leadership who keep learning and adapting.

Examples mentioned:

A promoter/leader pursuing an executive course at Harvard at approximately age 61
Using annual report “management speak” to understand management’s view of trends

Companies referenced:

DVS
Infosys (noted as “not doing well right now,” per subtitles)

E = Ethics (forensic / promoter quality) + accounting risk

The presenter frames promoter behavior in India as relatively “black and white,” emphasizing forensic risk checks such as:

Aggressive accounting
Revenue inflation / recognition issues
Hidden liabilities
Potential for forensic checks like:
- excess payments to auditors
- political affiliation / dependence on government contracts (B2G)
- frequency of SEBI fines
- promoter entities repeating NCLT proceedings

A scenario example mentioned includes:

infra/capital goods linked to government contracts (risks when government changes)
a “JP Group” donation-related concern (details unclear)

S = Scale-ability / think big

Evaluate whether the company can scale into larger markets and future categories.

Examples:

Reliance: shift from oil & gas toward tech via Jio platforms
Conglomerate versatility: Tata and Reliance noted as rare examples
Smaller firms can scale more easily (as per the presenter’s view)

AI framing (high level):

Building stage (infrastructure/semiconductors/hardware spending)
Adoption stage
Learning stage
mid-sized Indian tech companies positioned as potential beneficiaries

Explicit “hard filters” (quant + quality checks)

After MILES, the framework is translated into metrics:

ROCE/ROC-style return filter
- Emphasis on return on capital ~15% as a major criterion (attributed to Bharat Shah / ASK).
- Practical interpretation: look for ~15%+ return on capital/ROC/ROCE consistently.
- Claim made: out of ~7000 companies, only ~4500 meet (subtitle unclear—framed as a large subset not meeting the criterion).
- Warning: don’t rely on a single quarter.
Free Cash Flow (FCF) generation
- Focus on cash, not just book profits.
- Examples:
  - Zee: strong book profits, but bad debt increased; payments to own companies not coming (as referenced)
  - Vodafone: FCF negative for multiple years while debt increased
Valuation matrix Valuation depends on business type:
- “New age” businesses:
  - consider P/S
  - if profitable then P/E
- Capital-intensive businesses:
  - use EV/EBITDA
  - rule-of-thumb framing: EV/EBITDA = 10 implies recovering enterprise value from ~10 years of earnings (conceptual interpretation)
Bottom-line focus
- Repeated emphasis: prioritize earnings and cash flow, avoid getting carried away by narratives or order books.

Portfolio construction & risk management guidance

Diversification vs concentration

Diversification is presented as important because even top investors make mistakes.
Concentration examples referenced:
- Rakesh Jhunjhunwala taking major losses in some stocks (example cited: DHFL; also mentions A2G).
Position sizing guidance (personal):
- “I usually don’t go beyond 10% in a stock” (not presented as a strict universal rule).
Retail caution:
- Only hold as many stocks as you can research well. If you can’t track closely, concentration can become risky.

How many stocks?

Example:
- Peter Lynch: about ~28% gain over 20 years with about ~100 stocks
Another example mentioned:
- Warren Buffett: large concentration (subtitles suggest ~45% in Apple, exact timing uncertain)

Liquidity risk

Check liquidity (ability to exit without massive cost).
Avoid getting stuck in small/micro-cap stocks during bad periods.

SIP + ongoing monitoring

Suggested approach:
- SIPs in mutual funds
- monitor holdings and keep learning/improving
Personal activity described as still active with about ~50% SIP (amount details partially garbled).

Timing of buying: SIP vs lump sum

SIP works better when cash flows are regular (salary-like).
Lump sum / staggered investing may fit irregular-income situations (actor/contractor scenario).
Conviction should build gradually; increase positions over time rather than all at once.

Market/sector timing cautions

Avoid chasing peaks/themes:
- when “everyone” follows a theme and NFOs arrive at maximum interest, price discovery may already be done and emotions may dominate.
Cyclicality & government-intervention caution for concentrated investing:
- Avoid highly cyclical or government-intervention-heavy sectors (examples: infra, oil & gas, telecom).
Example cited:
- Tejas Networks: 5G/BSNL-related order delays led to losses; sharp movement in subtitles from ~1500 to ~400–500.

Instruments / tickers / companies mentioned

Companies / tickers

Nvidia (NVDA)
Apple (AAPL)
Maruti Suzuki
DBS (bank referenced)
Sun Pharma
Aurobindo Pharma
Neuland Labs
Laurus Labs
Reliance (Reliance Industries)
Jio platforms / Jio
Infosys
Asian Paints
Pidilite
Astral
Murugappa Group
Chola Tube Investments
CG Power
Tata / “Tata of South” (as referenced)
Shree Cement
Eternal (context unclear; possibly a company name)
Tejas Networks
BSNL
Zee
Dish TV, Siti Cable
Vodafone
JP Group (mentioned as an example)
DHFL
A2G
Titan
Netflix
Motilal (Motilal Oswal referenced indirectly as “Motilal” investor/fund)

Metrics / instruments / indices (mentioned)

ROCE / ROC and “return on capital 15%” filter
Free Cash Flow (FCF)
EV/EBITDA
P/E
Price-to-Sales (P/S)
Cash flow statement, P&L, balance sheet
NFOs (mutual fund new fund offers)

Drug / biotech references

Mounjaro (GLP-1)
Alli (name appears; intended meaning unclear due to subtitle errors)

Key numbers and explicit thresholds

Market drawdown scenario: 30–50%
Return filter: ROC/return on capital ~15% consistently
Staff scientist example:
- ~1200 scientists
- ~25% of ~5000 employees
Margin decline example (Maruti):
- margins fell from double digit to single digit
- stock delivered weak returns for ~6–7 years
Position sizing guidance: typically ≤10% per stock
EV/EBITDA rule-of-thumb:
- EV/EBITDA = 10 ⇒ recover EV in ~10 years of earnings (conceptual)

Disclosures / disclaimers

“Investment and securities markets are subject to market risk.”
“Read all the related documents carefully before investing.”
Risk disclosure referenced for: equity shares, derivatives, mutual funds, and all other instruments.

Presenters / sources (as stated)

Gurmeet (guest; wealth manager / interviewee explaining the framework)
Arunima Rao (signing off; likely host/producer voice in subtitles)
Bharat Shah (founder of ASK) — credited for the 15% return on capital screening idea
Rakesh Jhunjhunwala, Warren Buffett, Peter Lynch (used as historical examples)

The Exact Formula to Pick Stocks in 25 Mins by ₹4,000 Crore Wealth Manager Formula

Key takeaways